Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jatin Machhi

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Frontiers in Pharmacology|May 12, 2025
Editorial: Targeting neuroinflammation for novel therapeutics in neurodegenerative diseasesPukar Khanal, Rupesh Chikhale, Jatin Machhi
Scientific Reports|January 28, 2018
New role of phenothiazine derivatives as peripherally acting CB1 receptor antagonizing anti-obesity agentsMayank Kumar Sharma, Jatin Machhi, Prashant Murumkar, et al.
Molecular Neurobiology|November 9, 2016
Dexamethasone Alters the Appetite Regulation via Induction of Hypothalamic Insulin Resistance in Rat BrainRagitha Chruvattil, Shreya Banerjee, Sarmi Nath, et al.
Journal of Neuroimmunology|March 26, 2018
Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease miceTomomi Kiyota, Jatin Machhi, Yaman Lu, et al.
Molecular Neurodegeneration|June 7, 2020
Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disordersJatin Machhi, Bhavesh D Kevadiya, Ijaz Khan Muhammad, et al.
Pharmaceutics|March 26, 2022
Prodrug Therapies for Infectious and Neurodegenerative DiseasesMilica Markovic, Suyash Deodhar, Jatin Machhi, et al.
Neurobiology of Disease|January 25, 2020
Immunotherapy for Parkinson's diseaseAaron D Schwab, Mackenzie J Thurston, Jatin Machhi, et al.
Bioorganic Chemistry|June 5, 2015
Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesisAshish M Kanhed, Anshuman Sinha, Jatin Machhi, et al.
Clinical and Translational Medicine|July 8, 2022
Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's diseaseMai M Abdelmoaty, Jatin Machhi, Pravin Yeapuri, et al.
Journal of Neuroinflammation|May 7, 2018
URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer's diseaseTomomi Kiyota, Jatin Machhi, Yaman Lu, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Frontiers in Pharmacology|May 12, 2025
Editorial: Targeting neuroinflammation for novel therapeutics in neurodegenerative diseasesPukar Khanal, Rupesh Chikhale, Jatin Machhi
Scientific Reports|January 28, 2018
New role of phenothiazine derivatives as peripherally acting CB1 receptor antagonizing anti-obesity agentsMayank Kumar Sharma, Jatin Machhi, Prashant Murumkar, et al.
Molecular Neurobiology|November 9, 2016
Dexamethasone Alters the Appetite Regulation via Induction of Hypothalamic Insulin Resistance in Rat BrainRagitha Chruvattil, Shreya Banerjee, Sarmi Nath, et al.
Journal of Neuroimmunology|March 26, 2018
Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease miceTomomi Kiyota, Jatin Machhi, Yaman Lu, et al.
Molecular Neurodegeneration|June 7, 2020
Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disordersJatin Machhi, Bhavesh D Kevadiya, Ijaz Khan Muhammad, et al.
Pharmaceutics|March 26, 2022
Prodrug Therapies for Infectious and Neurodegenerative DiseasesMilica Markovic, Suyash Deodhar, Jatin Machhi, et al.
Neurobiology of Disease|January 25, 2020
Immunotherapy for Parkinson's diseaseAaron D Schwab, Mackenzie J Thurston, Jatin Machhi, et al.
Bioorganic Chemistry|June 5, 2015
Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesisAshish M Kanhed, Anshuman Sinha, Jatin Machhi, et al.
Clinical and Translational Medicine|July 8, 2022
Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's diseaseMai M Abdelmoaty, Jatin Machhi, Pravin Yeapuri, et al.
Journal of Neuroinflammation|May 7, 2018
URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer's diseaseTomomi Kiyota, Jatin Machhi, Yaman Lu, et al.
Pageof 4